Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 26;13(5):760.
doi: 10.3390/genes13050760.

Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms

Affiliations

Central Core Disease: Facial Weakness Differentiating Biallelic from Monoallelic Forms

Ana Cotta et al. Genes (Basel). .

Abstract

Central Core Disease (CCD) is a genetic neuromuscular disorder characterized by the presence of cores in muscle biopsy. The inheritance has been described as predominantly autosomal dominant (AD), and the disease may present as severe neonatal or mild adult forms. Here we report clinical and molecular data on a large cohort of Brazilian CCD patients, including a retrospective clinical analysis and molecular screening for RYR1 variants using Next-Generation Sequencing (NGS). We analyzed 27 patients from 19 unrelated families: four families (11 patients) with autosomal dominant inheritance (AD), two families (3 patients) with autosomal recessive (AR), and 13 sporadic cases. Biallelic RYR1 variants were found in six families (two AR and four sporadic cases) of the 14 molecularly analyzed families (~43%), suggesting a higher frequency of AR inheritance than expected. None of these cases presented a severe phenotype. Facial weakness was more common in biallelic than in monoallelic patients (p = 0.0043) and might be a marker for AR forms. NGS is highly effective for the identification of RYR1 variants in CCD patients, allowing the discovery of a higher proportion of AR cases with biallelic mutations. These data have important implications for the genetic counseling of the families.

Keywords: RYR1; central core disease; clinical heterogeneity; electromyography.

PubMed Disclaimer

Conflict of interest statement

Ana Cotta, Lucas Santos Souza, Elmano Carvalho, Leticia Nogueira Feitosa, Antonio Cunha-Jr, Monica Machado Navarro, Julia Filardi Paim, Jaquelin Valicek, Miriam Melo Menezes, Simone Vilela Nunes Neves, Rafael Xavier-Neto, Antonio Pedro Vargas, Reinaldo Issao Takata, and Mariz Vainzof declare that there are no conflit of interest.

Figures

Figure 1
Figure 1
(A)—Distribution of the studied families, according to the pedigrees. (B)—Distribution of the 14 families with genetic studies, according to the presence of mono or biallelic variants in RYR1.
Figure 2
Figure 2
Imaging and muscle biopsy findings of patient 2.1 with the p.Gly4897Asp pathogenic variant in the RYR1 gene. (A)—Computed tomography demonstrated severe right vastus lateralis (vl) muscle fat replacement with relative rectus femoris (rf) preservation. Computed tomography of the pelvis, thighs, and legs. (B)—Muscle biopsy was performed in the rectus femoris demonstrating round core structures (*). SDH 100x. (C)—Core areas (*) were ultrastructurally characterized by myofibrillar disorganization with scarce mitochondria. Transmission electron microscopy 2500×. This figure was modified from Cotta et al., 2021 [6].
Figure 3
Figure 3
Diagram of the variants in the RYR1 gene in this cohort of patients. Novel variants identified in this work are depicted in red and previously described variants are represented in black. D1, D2, and D3 are the three hotspots for mutations in the RYR1 gene, and the majority of the variants identified in this cohort are located at D3. Figure created using IBS Illustrator for Biological Sequences [19].
Figure 4
Figure 4
Facial weakness in biallelic and monoallelic RYR1 families.

References

    1. Dubowitz V., Brooke M.H. Muscle Biopsy: A Modern Approach. W. B. Saunders Company Ltd.; Philadelphia, PA, USA: 1973.
    1. Dubowitz V., Sewry C.A., Oldfors A. Muscle Biopsy: A Practical Approach. 5th ed. Elsevier Ltd.; Beijing, China: 2021.
    1. Karpati G., Hilton-Jones D., Bushby K., Griggs R.C. Disorders of Voluntary Muscle. 10th ed. Cambridge University Press; Cambridge, UK: 2010.
    1. Jungbluth H., Sewry C.A., Muntoni F. Core Myopathies. Semin. Pediatr. Neurol. 2011;18:239–249. doi: 10.1016/j.spen.2011.10.005. - DOI - PubMed
    1. Amburgey K., Bailey A., Hwang J.H., Tarnopolsky M.A., Bonnemann C.G., Medne L., Mathews K.D., Collins J., Daube J.R., Wellman G.P., et al. Genotype-Phenotype Correlations in Recessive RYR1-Related Myopathies. Orphanet J. Rare Dis. 2013;8:117. doi: 10.1186/1750-1172-8-117. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances